BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35485284)

  • 1. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
    Wang J; Pan X; Li J; Zhao J
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation.
    Sheng L; Kang Y; Chen D; Shi L
    Mol Med Rep; 2023 Sep; 28(3):. PubMed ID: 37539739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-643 Functions as a Potential Tumor Suppressor in Gastric Cancer by Inhibiting Cell Proliferation and Invasion
    Wu Y; Ye H; Peng B; Jiang H; Tang Q; Liu Y; Xi J; Chen S
    Ann Clin Lab Sci; 2021 Jul; 51(4):494-502. PubMed ID: 34452887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
    Zhang H; Cao Y; Tang J; Wang R
    Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XBP1s promotes the development of lung adenocarcinoma via the p‑JNK MAPK pathway.
    Jiang H; Jiang Q; He Y; Li X; Xu Y; Liu X
    Int J Mol Med; 2022 Mar; 49(3):. PubMed ID: 35059734
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
    Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
    Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma.
    He Z; Zhang H; Xiao H; Zhang X; Xu H; Sun R; Li S
    J Transl Med; 2024 Feb; 22(1):216. PubMed ID: 38424632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
    Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
    Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
    Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
    J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment.
    Li Y; Liu Y; Wang K; Xue D; Huang Y; Tan Z; Chen Y
    Mediators Inflamm; 2023; 2023():8646088. PubMed ID: 37181807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
    Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
    Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.